$Monopar Therapeutics (MNPR.US)$ Monopar Therapeutics Inc (MNPR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from JonesTrading upgraded the rating on the stock to a Buy and gave it a $2.00 price target.
$Infobird Software (IFBD.US)$ is time to fly
1
1
$Connexa Sports Technologies (CNXA.US)$ time to fly - fly fly fly higher
2
$Roma Green Finance (ROMA.US)$come on, you can be better. fly higher